Regeneron Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
TARRYTOWN, N.Y., Dec. 18, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. The presentation is scheduled for 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time) and may be accessed from the “Investors & Media” page of Regeneron’s website at http://investor.regeneron.com/events-and-presentations. A replay and transcript of the webcast will be archived on the Company’s website for at least 30 days.
Related news for (REGN)
- Regeneron Announces Investor Conference Presentations
- Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
- Linvoseltamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Multiple Myeloma
- Regeneron Announces Formation of Regeneron Cell Medicines with the Acquisition of 2seventy bio Platforms and Preclinical and Clinical Programs
- Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)